• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    NiKang Unveils First-in-Class Dual Inhibitor NKT5097 at SABCS

    BUSINESSWIRE

    NiKang Therapeutics Completes First Phase 1 Dosing of NKT5097

    BUSINESSWIRE

    NiKang Completes First Cohort Dosing In Ph1 NKT3964 CDK2 Study

    BUSINESSWIRE

    NiKang Doses First Patient In Ph 1b/2 Of NKT2152 For Liver Cancer

    BUSINESSWIRE

    NiKang Therapeutics Presents NKT3964 PROTAC Degrader For Cancer

    BUSINESSWIRE

    NiKang To Present NKT2152 Data For Renal Cell Carcinoma At ESMO

    BUSINESSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.